DE60132323D1 - Frühen diagnose von blasentumor in urinproben - Google Patents

Frühen diagnose von blasentumor in urinproben

Info

Publication number
DE60132323D1
DE60132323D1 DE60132323T DE60132323T DE60132323D1 DE 60132323 D1 DE60132323 D1 DE 60132323D1 DE 60132323 T DE60132323 T DE 60132323T DE 60132323 T DE60132323 T DE 60132323T DE 60132323 D1 DE60132323 D1 DE 60132323D1
Authority
DE
Germany
Prior art keywords
marker
early diagnosis
urine samples
rna
blood tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60132323T
Other languages
English (en)
Inventor
Giorgio Stanta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macrochip SRL
Original Assignee
Macrochip SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macrochip SRL filed Critical Macrochip SRL
Application granted granted Critical
Publication of DE60132323D1 publication Critical patent/DE60132323D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514—CD4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
DE60132323T 2000-05-08 2001-05-04 Frühen diagnose von blasentumor in urinproben Expired - Lifetime DE60132323D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI001002A IT1318504B1 (it) 2000-05-08 2000-05-08 Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina.
PCT/EP2001/005054 WO2001086288A2 (en) 2000-05-08 2001-05-04 Early diagnosis of bladder tumor in urine samples

Publications (1)

Publication Number Publication Date
DE60132323D1 true DE60132323D1 (de) 2008-02-21

Family

ID=11444995

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60132323T Expired - Lifetime DE60132323D1 (de) 2000-05-08 2001-05-04 Frühen diagnose von blasentumor in urinproben

Country Status (6)

Country Link
EP (1) EP1281087B1 (de)
AT (1) ATE383578T1 (de)
AU (1) AU2001270505A1 (de)
DE (1) DE60132323D1 (de)
IT (1) IT1318504B1 (de)
WO (1) WO2001086288A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1355158A1 (de) * 2002-04-19 2003-10-22 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Diagnose von Entzündungserkrankungen und Infektionen unter Bestimmung des Phosphoproteins LASP-1 als Inflammationsmarker
US7217515B2 (en) 2002-09-30 2007-05-15 Chi Mei Foundation Medical Center HURP gene as a molecular marker for bladder cancer
WO2006012522A1 (en) * 2004-07-23 2006-02-02 Pacific Edge Biotechnology Ltd. Urine markers for detection of bladder cancer
ES2304306B1 (es) * 2007-03-20 2009-07-07 Indas Biotech, S.L.U. Metodo de diagnostico y/o pronostico de cancer vesical.
GB201814040D0 (en) * 2018-08-29 2018-10-10 Oncologica Uk Ltd Testing and therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863726A (en) * 1993-11-12 1999-01-26 Geron Corporation Telomerase activity assays
JPH09262100A (ja) * 1996-03-27 1997-10-07 Mount Sinai School Medicine City Univ New York テロメラーゼ活性の存在を測定することによる尿試料中のヒト膀胱癌細胞の検出方法
WO1998000563A1 (fr) * 1996-06-28 1998-01-08 Chugai Seiyaku Kabushiki Kaisha Procede de detection d'une activite telomerase
DE69739497D1 (de) * 1996-10-01 2009-08-27 Geron Corp Menschlische Telomerase katalytische Untereinheit
DE19757300A1 (de) * 1997-12-22 1999-06-24 Roche Diagnostics Gmbh Nachweis von Harnblasenkarzinom in einer Urinprobe

Also Published As

Publication number Publication date
WO2001086288A2 (en) 2001-11-15
AU2001270505A1 (en) 2001-11-20
EP1281087A2 (de) 2003-02-05
ITMI20001002A0 (it) 2000-05-08
ATE383578T1 (de) 2008-01-15
EP1281087B1 (de) 2008-01-09
IT1318504B1 (it) 2003-08-27
ITMI20001002A1 (it) 2001-11-08
WO2001086288A3 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
SE0000538D0 (sv) Methods and kits for proximity probing
SE9601318D0 (sv) Method for nucleic acid analysis
ATE419388T1 (de) Nukleinsäureanreicherung
EA200200698A1 (ru) Способ выделения рнк из фиксированных формалином и залитых в парафин образцов ткани
DK1141728T3 (da) Påvisning af nyresygdom og behandling deraf
ATE319093T1 (de) Verfahren zur diagnose von leberkrankheit unter verwendung von biochemischen merkmalen
ATE275642T1 (de) Verfahren zur diagnose von krebs
BR0010068A (pt) Sistema de identificação do marcador fenotìpico e biológico
ATE335815T1 (de) Isolierung von nukleinsäuren
ATE452338T1 (de) Nachweisverfahren für eine frühe nierenkrankheit in tieren
ATE513851T1 (de) Menschliches gen zur fruchtbarkeit entscheidend
DE60132323D1 (de) Frühen diagnose von blasentumor in urinproben
ES2183399T3 (es) Metodo para la determinacion del funcionamiento del higado.
WO2003100006A3 (en) Method of improved prostate cancer detection
WO2005033330A3 (en) Fluorescent probes for use in protein kinase inhibitor binding assay
ATE372392T1 (de) Verfahren zur bestimmung der menge einer zielnukleinsäure in einer probe
DK1214447T3 (da) Påvisning af pyruvatkinase-isoenzymer i fæces
CA2518933A1 (en) Method of detecting colon cancer marker
DE69604051T2 (de) Verfahren zum sensitiven nachweis von reverser transcriptase
DE602005024254D1 (de)
ATE427494T1 (de) Verfahren zur quantifizierung der akt-protein- expression
DE60332370D1 (de) Bakterientestverfahren mit bindung einer intrazellularer enzyme
DK1057021T3 (da) Fremgangsmåde til måling af totalanalyt
ATE509270T1 (de) Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung
DE60038029D1 (de) Methoden und reagenzien zur in situ amplifizierung

Legal Events

Date Code Title Description
8332 No legal effect for de